| |
|||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
| EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 11, Number 9, September 2005 Potential Impact of Antiviral Drug Use during Influenza PandemicRaymond Gani,* Helen Hughes,* Douglas Fleming,† Thomas Griffin,* Jolyon
Medlock,* and Steve Leach* |
||
|
|
![]() |
|
| Back to article | |
|
Figure 1. Estimated impact of different sizes of antiviral stockpiles on the number of clinical cases at the end of the pandemic. Depicted are clinical attack rates before interventions of 20%, 25%, 30%, 35%, and 40%, with corresponding values for the basic reproduction number (R0) of 1.28, 1.39, 1.53, 1.72, and 2.0 respectively. The precipitous decreases observed with the 20% and 25% attack rates result at the points at which the stockpile becomes large enough to last long enough to prevent a recrudescence of the epidemic by suppressing the effective reproduction number. |
|
|
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
|
This page last reviewed August 17, 2005 |
|
|
Emerging
Infectious Diseases Journal |
|